EN
Home/Guides/Getting a prescription
Guide 6 of 9 · Stage: Do it safely

Getting a prescription in Canada, and the medicines

First the prescription: who can prescribe, who pays, and the rules for online care. Then the medicines: what Health Canada has approved, generics and recalls, storage in a Canadian winter, and the official prices.

The short answer

GLP-1 medicines are prescription drugs in Canada. A family doctor or nurse practitioner can prescribe them, in person or online. Provincial drug plans cover semaglutide for type 2 diabetes with conditions, but no provincial plan covers any GLP-1 for weight management (as of 12 Oct 2026), so most people use private insurance or pay themselves. Fill prescriptions only at a licensed pharmacy and check the DIN on the box. Talk to a doctor before starting, stopping or changing any medicine.

Key facts

Prescription
Always. All GLP-1 medicines are prescription drugs in Canada.1
Who prescribes
Family doctors and nurse practitioners; no specialist needed. Some Alberta pharmacists can prescribe too.2,3
Public plans
Semaglutide covered for type 2 diabetes, with conditions; nothing covered for weight management (as of 12 Oct 2026)4,5
Online
Allowed, but a doctor seeing you online must meet the same standard of care as in person11
$Official prices
  • Generic semaglutide (for diabetes): $78.14 a pen on Ontario's plan
  • Ozempic: $227.94 a pen on Ontario's plan
  • Wegovy: $388.64 a pen in the 2025 federal review6,7
Fakes and recalls
Health Canada warns about fake Ozempic and Mounjaro; some generic semaglutide lots were recalled in August 202620,22
On this page
  1. Who can prescribe a GLP-1 in Canada?
  2. Who pays: public plans and private insurance
  3. What will I pay, and can I claim it on my taxes?
  4. What rules apply to online care?
  5. How do I check a pharmacy?
  6. What should a proper consultation include?
  7. What are the red flags?
  8. Questions to ask a provider
  9. Which GLP-1 medicines are approved, and for what?
  10. Brand or generic: what's the difference?
  11. Pen or tablet?
  12. Fakes, recalls and storage
  13. What are the official prices?
  14. What does a year cost?
  15. Questions people ask
1See a licensed prescriber: your family doctor, a nurse practitioner, or a clinic
2Your history, and your weight and health checked properly
3A prescription for a Health Canada-approved medicine, and a check of your coverage
4A licensed pharmacy, a pack with a DIN, kept cold and never frozen
5Follow-up while the dose goes up, and regular reviews

The order this guide follows. The prescriber comes first; the medicine comes second.

Part AGetting a prescription

Who can prescribe a GLP-1 in Canada?

Any licensed prescriber, within their province's rules. You don't need a specialist.

All GLP-1 medicines are on Health Canada's prescription schedule.1 Physicians, including family doctors, and nurse practitioners prescribe them. Clinicians who gave input to Canada's Drug Agency said any provider with experience managing obesity could prescribe semaglutide, and that this shouldn't be limited to specialists.2

Pharmacists. In Alberta, pharmacists with additional prescribing authorization (about two-thirds of the province's clinical pharmacists at the end of 2025) can prescribe to start, continue or stop medicines. We found no specific guidance on whether they start GLP-1s for weight.3 Rules differ by province. See can a pharmacist prescribe Ozempic?

Approved use matters. For weight management, Health Canada has approved Wegovy, Zepbound, Saxenda and Sevmia (a generic of Wegovy). Ozempic and Mounjaro are approved for type 2 diabetes; using them for weight is off-label (outside the approved use), which a prescriber may do on their own judgment.1,8

Who pays: public plans and private insurance

Each province and territory runs its own drug plan. As of 12 Oct 2026, they cover semaglutide for type 2 diabetes with conditions, and no GLP-1 for weight management.4,5

  • For type 2 diabetes. Ontario, BC, Alberta, Quebec and the federal NIHB program (for First Nations and Inuit) cover semaglutide, usually after metformin, with forms or criteria. Generic semaglutide is listed as interchangeable in Ontario and Alberta.5,6,9,10 We found no province that covers tirzepatide (Mounjaro).6,10
  • For weight management. Canada's Drug Agency recommended funding Wegovy only for people with established heart disease, at a much lower price. Price talks ended without agreement in December 2025, and Novo Nordisk said it would no longer seek public coverage.4,12
  • In Ontario, drug coverage comes through the Ontario Drug Benefit program, for people who qualify (for example, people 65 and over, those under 25 without private coverage through OHIP+, and people on social assistance).13
  • In Quebec, drug insurance is mandatory: if you can join a group plan through work (assurance collective), you must; otherwise RAMQ's public plan (régime public d'assurance médicaments) covers you.14 RAMQ lists Ozempic as an exception drug (médicament d'exception) for type 2 diabetes.10
  • Private insurance. Only a small number of private insurers cover these medicines for weight management, often with a prior authorization form, BMI rules or step therapy.15,16

Guide 4 has the plan-by-plan table. See also does your province cover Ozempic? and private insurance and GLP-1s.

What will I pay, and can I claim it on my taxes?

It depends on your plan. If no plan covers it, you pay the pharmacy's price in full. Prescription medicines can count toward the federal Medical Expense Tax Credit.

  • Ask before you fill it. Your pharmacist can tell you what your public plan or insurer will pay, and whether a form is needed first.
  • Tax credit. The Canada Revenue Agency counts prescription drugs that can lawfully be obtained only with a prescription, and that a pharmacist records, as eligible medical expenses. Needles and syringes count too, with a prescription.17 It's a non-refundable tax credit, not a deduction. See claiming GLP-1s on your taxes.
  • Savings cards and promotions. Some makers and services offer cards or promotional prices. We don't show those, because they aren't the list price and the terms change.

What rules apply to online care?

Virtual care is allowed, but the rules are the same as in person. Doctors are licensed by province, and so are pharmacies.

Ontario's College of Physicians and Surgeons, for example, says doctors giving virtual care:11

  • Must meet the same standard of care as in person, including when prescribing drugs.11
  • Must consider whether a physical examination is needed.11
  • Must follow the licensing rules of the province you're in, if they see you from another province.11

We didn't check every province's college one by one, so ask your own college or the service if you're unsure. We found no Canadian enforcement action against a named GLP-1 online service; Health Canada's warnings so far have been about fake, unauthorized and compounded products.20,21,23 See getting a GLP-1 prescription online in Canada.

Why we don't name any seller. Canadian law bans advertising any drug to the public as a treatment for obesity or diabetes, and limits ads for prescription drugs to the name, price and quantity.18,19 We explain the rules and how to check a provider; we don't list, rank or price any pharmacy, clinic or program, and we take no money from them. Guide 7 explains the types of provider and what to check.

How do I check a pharmacy?

Pharmacies are licensed by your province's pharmacy regulator. Health Canada's own advice is simple: buy prescription drugs only from a licensed pharmacy, and check the DIN.20

  1. Look the pharmacy up on your province's regulator website. In Ontario, every pharmacy must be licensed by the Ontario College of Pharmacists, which has a public register.24 Other provinces have their own regulators, such as the Alberta College of Pharmacy and the Ordre des pharmaciens du Québec.25
  2. Check the name and address match what the pharmacy shows on its website.
  3. Check the DIN. Every approved product has an 8-digit Drug Identification Number on the label. Look it up in Health Canada's Drug Product Database.20
No national logo to look for. We found no Canada-wide online-pharmacy logo scheme. The provincial register and the DIN are your checks. Health Canada says some fake sellers misuse official logos and fake endorsements.20

What should a proper consultation include?

Questions about your health and medicines, your weight and waist checked properly, and a plan for follow-up.

There's no single official checklist for a GLP-1 consultation. This list brings together what the Canadian guideline, the virtual-care standard and the medicines' labels say a prescriber should check.8,11,26

  • Your history. Medullary thyroid cancer or MEN 2 (multiple endocrine neoplasia type 2, a rare inherited condition) in you or your family rules these medicines out.8 Past pancreatitis or gallstones matter too.26
  • Your other medicines. Insulin, or diabetes tablets like gliclazide, can cause low sugar (hypos) when combined with a GLP-1.26 The dose of those may need to drop.
  • Your weight and waist, checked. The guideline asks doctors to use waist size and ethnicity-specific measures as well as BMI.8 Guide 1 explains the numbers.
  • Eyes, if you have diabetes. The label warns about worse eye disease (retinopathy) in people who already have it.26
  • Pregnancy and contraception. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before a planned pregnancy. On tirzepatide, switch from the pill to another method or add a condom for 4 weeks after starting and after each dose increase.8
  • Any surgery or procedure coming up. These medicines slow how fast the stomach empties, so food can still be there under anesthesia. Tell the team doing the procedure that you take one.8,26
  • Your coverage. Whether your plan pays, and whether a prior authorization form is needed.16
  • A follow-up plan. Who you contact with side effects, and regular reviews of how it's working against your health goals.8

What are the red flags with a pharmacy, clinic or app?

Walk away if you can't check who they are, if nobody looks at your health properly, or if the product isn't a Health Canada-approved medicine.

  • Not a licensed pharmacyHealth Canada says to buy prescription drugs only from a licensed pharmacy.20
    Shows its name and address, and both check out with the provincial regulator.
  • No real assessmentOnline care must meet the same standard as in person, including considering whether you need an exam.11
    Takes a full history, checks your measurements, and asks to share with your family doctor.
  • "Research peptides" or "no prescription needed"Health Canada has warned that injectable "peptides" such as tirzepatide and retatrutide sold online are illegal.21
    Supplies only an approved product with a DIN, against a prescription.20
  • A "compounded" versionHealth Canada doesn't allow routine compounding of semaglutide, and the Canadian guideline recommends against compounded products.23,8
    A Health Canada-approved pen or tablet in its sealed pack.
  • Ads promising weight loss with a named drugAdvertising a drug to the public as a treatment for obesity or diabetes is banned in Canada.18
    Offers a consultation first; the medicine is discussed only after it.

Questions to ask a provider

Take these to the consultation. A good prescriber will be glad you asked.

  1. Who is the prescriber, and which province are they licensed in?
  2. Which pharmacy will fill it, and is it licensed in my province?
  3. Is this medicine approved in Canada for my condition, or would it be off-label?
  4. Will my public plan or insurance cover it? Do you need to fill in a form?
  5. What else should I try first or alongside it?
  6. Which side effects should make me contact you, and how do I reach you?
  7. How will my dose go up, and who decides each step?
  8. Does it affect my other medicines, my contraception or a pregnancy plan?
  9. What will it cost per month at the full dose?
  10. What happens when I stop, and how long would I take it?
Part BThe medicines in Canada

Before you go further

  • Prescription only. Never start one without a prescriber.1
  • Know the risks first. Guide 5: Side effects and risks.
  • No promise of results. Weight loss varies a lot from person to person, and some people lose little.

We list brands and official prices as facts. We don't recommend any brand, company or seller, and we earn nothing from them.

Which GLP-1 medicines are approved in Canada, and for what?

Four medicines. Semaglutide and tirzepatide each have a diabetes brand and a weight brand; liraglutide has both; dulaglutide is for type 2 diabetes only. Status checked 12 Oct 2026.

The medicine is what works in your body; the brand is the name on the box. Acetaminophen is a medicine; Tylenol is a brand of it. One medicine can have several brands, each approved for different uses.1

Diabetes approved for type 2 diabetes Weight approved for weight management

  • WegovyWeight26
    Weekly pen; Novo NordiskAlso approved to lower the risk of a non-fatal heart attack in people with heart disease, for teens 12 and over who weigh more than 60 kg (132 lb), and for a scarring fatty liver disease, MASH (conditional, October 2026).26
  • OzempicDiabetes27
    Weekly penAlso approved to lower heart and kidney risk in some people with type 2 diabetes. Not approved for weight loss; using it for that is off-label.27
  • RybelsusDiabetes28
    Daily tablet
  • Generic semaglutideDiabetesWeight29
    Weekly pen; several makersGenerics of Ozempic are for diabetes; Sevmia, a generic of Wegovy, is for weight but not yet on sale. See below.29
  • ZepboundWeight30
    Weekly 4-dose KwikPen; Eli LillyAlso approved for moderate to severe sleep apnoea in adults with obesity (June 2026).30
  • MounjaroDiabetes1
    Weekly pen; Eli LillyFor type 2 diabetes only, in adults and children 10 and over. Using it for weight is off-label.1
  • SaxendaWeight1
    Daily pen
  • VictozaDiabetes1
    Daily pen
  • TrulicityDiabetes1
    Weekly pen

Not approved in Canada as of 12 Oct 2026: orforglipron, retatrutide, CagriSema and the higher-dose Wegovy tablet.1

Brand or generic: what's the difference?

A generic is the same medicine made by another company once patents and data protection end. In April 2026, Canada became the first G7 country to approve a generic semaglutide.31

Semaglutide's data protection in Canada ended on 4 January 2026, and the main patent had already lapsed.32 Health Canada's Drug Product Database showed this on 12 Oct 2026 (alphabetical by maker, not a ranking):29

ProductCopy ofStatus
Apo-Semaglutide (Apotex)Ozempic, for type 2 diabetesApproved 1 May 2026; on sale from 14 May 2026
Aspen-Semaglutide and Semaglutide Injection (Aspen)Ozempic, for type 2 diabetesApproved July and August 2026; not yet on sale
Semaglutide Injection (Dr. Reddy's)Ozempic, for type 2 diabetesApproved 28 April 2026; on sale from 6 May 2026
Sandoz SemaglutideOzempic, for type 2 diabetesApproved 16 September 2026; not yet on sale
Sevmia (Apotex)Wegovy, for weight and heart attack riskApproved 29 June 2026; not yet on sale. Comes only as a pen giving 1 mg doses.

Novo Nordisk has also registered two more brands of its own semaglutide, Plosbrio and Poviztra; both were approved but not on sale.29

  • Supply has been patchy. Generics reached pharmacies in May 2026, but availability varied by region, and Dr. Reddy's reported a shortage from a manufacturing problem in July 2026.33,9
  • Some lots were recalled in August 2026. See recalls below.22
  • Sevmia's single 1 mg pen can't on its own cover Wegovy's lower starting steps (0.25 and 0.5 mg) or the 1.7 and 2.4 mg doses. That's our reading of the pen description, not a statement from the maker.34,26

Switching between brands is a decision for you, your prescriber and your pharmacist. In Ontario and Alberta, generic semaglutide is listed as interchangeable with Ozempic, so a pharmacist may substitute it, and the public plan pays the generic price.6,9 Pens from different makers can look and work differently, so ask to be shown how to use a new one. See generic semaglutide in Canada and switching from Ozempic to a generic.

Pen or tablet: does it matter?

GLP-1 injections in Canada come in pens that measure the dose for you. The only GLP-1 tablet, Rybelsus, is for type 2 diabetes and needs a strict routine.

A pre-filled injection pen with its cap off and a separate pen needlePenPre-filled, dose setA Wegovy FlexTouch, an Ozempic pen and a Zepbound KwikPen each hold 4 weekly doses; Wegovy also comes as a single-use pen.26,7,30 Never share a pen, even with a new needle.27
A tablet, a glass with a little water, a clock showing a half-hour wait and an empty plateTabletDaily, on an empty stomachRybelsus: swallow whole on an empty stomach with no more than 120 mL (half a glass) of water, then wait at least 30 minutes before food, drink or other tablets.28
A powder to mix is a warning sign. Approved products come ready to use, with a DIN. "Research peptide" powders sold online are illegal in Canada.21,20 If you think you've injected too much, call a poison centre on 1-844-POISON-X (1-844-764-7669), or 1-800-463-5060 in Quebec, or go to an emergency department, even if you feel fine.26,35 For severe stomach pain that won't go away, call 911.

Fakes, recalls and storage

Fake and unauthorized GLP-1s are sold in Canada, and real products are sometimes recalled. Only use a pack from a licensed pharmacy, against your prescription.20

Fakes. Health Canada warns that fake or unauthorized Ozempic and Mounjaro are sold in stores and online, some with misused official logos and fake endorsements (advisory updated January 2026).20 In August 2025 it warned that 41 unauthorized injectable "peptides", including tirzepatide and retatrutide, were sold online by one company.21

Recalls (August 2026). Some lots of Dr. Reddy's Semaglutide Injection were recalled for an impurity out of specification, and one lot for a 4 mg pen labelled as a 2 mg pen. One lot of Apo-Semaglutide was recalled because the pen could show and deliver 2 mg instead of 0.25 or 0.5 mg. Health Canada advised talking to your healthcare provider before stopping.22 See generic semaglutide recalls in 2026.

Check the pack when you pick it up

Something wrong? Don't use it. Keep the pen and packaging, tell the pharmacy, and report it to Health Canada's Canada Vigilance Program. Guide 5 explains how.

Keep it cold, never frozen

The single-use Wegovy pen can be kept below 30°C for a total of 28 days before its cap comes off.26 Rybelsus tablets need no fridge; keep them in their blister pack. Check your own pack leaflet. For winter and travel tips, see keeping pens safe in a Canadian winter.

Travelling to the US and back. Health Canada's personal-import guidance generally lets residents bring back prescription drugs that were prescribed and filled in Canada, up to a 90-day supply or one course of treatment, whichever is less.36 Keep pens in their labelled box, and plan how you'll keep them cool and away from freezing on the way.

What are the official prices?

The clearest official prices are in Ontario's public drug formulary and in Canada's Drug Agency reviews. They are not necessarily what you'll pay at the counter.6,7

Ontario's formulary lists the price its public plan pays for each product. Canada's Drug Agency publishes the price a maker submits for review. For tirzepatide, which isn't on any public formulary, the only figures we found are the maker's list prices as reported in the news. Pharmacies set their own prices and fees, so the price you pay can differ. We don't show pharmacy, clinic or savings-card prices.

Semaglutide, weekly pens (Ontario Drug Benefit formulary)

ProductPer pen (4 weekly doses)
Generic semaglutide (Apotex, Dr. Reddy's)$78.14
Ozempic (any strength listed)$227.94 (the plan pays the generic price)
Sevmia (1 mg pen)$325.05 (listed, but not a plan benefit)

Ontario Drug Benefit formulary, checked 12 Oct 2026. Ozempic and generic semaglutide are covered only for type 2 diabetes, under Limited Use criteria.6

Wegovy (semaglutide), weekly FlexTouch pen

StrengthPer pen (4 weekly doses)
All strengths$388.64

Canada's Drug Agency review SR0841 (the maker's submitted price; the pen costs the same at every dose). Its July 2025 recommendation put the yearly cost at $5,066. Checked 12 Oct 2026.7,4

Zepbound and Mounjaro (tirzepatide), weekly KwikPen

StrengthPer 4 weeks
2.5 mg and 5 mg$300
7.5 mg and 10 mg$420
12.5 mg and 15 mgNot published in the report we found

Eli Lilly's Canadian list prices from 29 Dec 2025, as reported by The Globe and Mail via Benefits and Pensions Monitor, 19 Dec 2025. Not an official formulary price. Checked 12 Oct 2026.37

How to read these prices
  • Each price is for one pen of 4 weekly doses, about a month.7,30
  • Why generics cost less. Under the pan-Canadian generic pricing framework, when three or more generics are listed, an injectable generic is priced at 35% of the brand's reference price. Ontario's generic price ($78.14) is about 34% of Ozempic's ($227.94).38,6
  • Rybelsus tablets are listed at $7.53 a tablet on Ontario's plan, for type 2 diabetes.6
  • Not published: we found no official Canadian price for Saxenda, or for tirzepatide's top two doses.

See GLP-1 prices in Canada and our cost calculator.

What does a year cost?

If your plan covers it, often little. If you pay yourself, the medicine alone comes to roughly $1,000 to over $5,000 a year, depending on the product and dose.

Work out your own cost

Choose a medicine. The cost calculator adds up the dose steps for 6 or 12 months at current prices, and you can change the plan.

Opens the cost calculator in a new tab. Nothing you choose leaves your device.

A year of weekly doses is 52 doses, or 13 four-dose pens. Using the prices above, the medicine alone for a year comes to about:6,7,37

At the prices above12 months
Generic semaglutide, for type 2 diabetes (13 pens at $78.14)$1,016
Ozempic, for type 2 diabetes (13 pens at $227.94)$2,963
Zepbound, staying on 5 mg (13 four-week supplies at $300)$3,900
Zepbound, rising to 10 mg (4 weeks each at 2.5, 5 and 7.5 mg, then 10 mg)$5,220
Wegovy, any dose (Canada's Drug Agency figure)$5,066

Zepbound rising to 10 mg: one 4-week supply each of 2.5 mg ($300), 5 mg ($300) and 7.5 mg ($420), then 10 more of 10 mg ($4,200) = $5,220. The label raises the dose by 2.5 mg at a time, at least 4 weeks apart.30 This is an example for the sum, not a suggestion; your prescriber decides your dose. What you pay at the pharmacy can differ. Wegovy at $388.64 for 13 pens is $5,052; Canada's Drug Agency's figure is slightly higher because it counts a full 365 days.7,4

Budget in years, not months: Guide 9 covers what happens when you stop. If you have private insurance, ask your insurer in writing what it covers before you count on it.

The risks, in brief

  • Feeling sick, vomiting, diarrhea and constipation are common, mostly when the dose goes up.26
  • Inflamed pancreas (pancreatitis): severe stomach pain that won't settle.26
  • Gallbladder problems, including gallstones.26
  • Losing too much fluid from vomiting or diarrhea can harm the kidneys.26
  • Not for people with medullary thyroid cancer or MEN 2 in themselves or their family.8
  • Not in pregnancy. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before a planned pregnancy.8
Read Guide 5: Side effects and risks →

Questions people ask

Can my family doctor prescribe Wegovy or Zepbound?

Yes. Family doctors and nurse practitioners can prescribe them; you don't need a specialist.2 Whether your plan pays is a separate question.

Does OHIP cover Ozempic?

OHIP itself doesn't pay for prescriptions. If you qualify for the Ontario Drug Benefit program, it covers Ozempic and generic semaglutide for type 2 diabetes when metformin hasn't been enough, and pays the generic price.13,6 It doesn't cover any GLP-1 for weight management.6,12 See does OHIP cover Ozempic?

Is there a generic Ozempic in Canada?

Yes. Dr. Reddy's and Apotex generics have been on sale since May 2026, for type 2 diabetes; others are approved but not yet sold.29,33 Some lots were recalled in August 2026.22

Is it safe to get a prescription online?

It can be, if the prescriber is licensed in your province and gives the same standard of care as in person, and the prescription is filled by a licensed pharmacy.11,20 Never buy "research peptides" or anything without a DIN.21

Is Ozempic approved for weight loss in Canada?

No. Ozempic is approved for type 2 diabetes. Wegovy is the semaglutide brand approved for weight management.27,26

Is Zepbound available in Canada?

Yes. Health Canada first approved it in May 2025 and it went on sale in July 2025, for weight management; sleep apnoea was added in June 2026.30,1

Are GLP-1s tax deductible in Canada?

Prescription medicines can count as eligible medical expenses for the Medical Expense Tax Credit. It's a credit, not a deduction.17

Can I keep the pen out of the fridge?

Unused pens go in the fridge, never frozen. After first use, Ozempic and the Wegovy FlexTouch can be kept below 30°C for up to 8 weeks, and a Zepbound KwikPen for up to 30 days.27,26,30 Check your own pack leaflet.

Before you move on

  • Your family doctor or nurse practitioner can prescribe; no specialist needed.
  • Check what your public plan or insurance covers before you fill it.
  • Online care is fine if it meets the same standard as in person.
  • Only a licensed pharmacy, and a product with a DIN: never "research peptides" or compounded versions.
  • Keep pens cold but never frozen, and budget for years, not months.
Was this guide easy to understand?

Sources

  1. Health Canada. Drug Product Database: product records, status and schedules for semaglutide, tirzepatide, liraglutide and dulaglutide products (all "Prescription"; Mounjaro for type 2 diabetes in adults and ages 10 to under 18; Zepbound first marketed 9 July 2025; Victoza, Saxenda, Trulicity marketed; orforglipron, retatrutide, cagrilintide and oral Wegovy not listed). Searched 12 October 2026. health-products.canada.ca
  2. Canada's Drug Agency (CDA-AMC). Semaglutide (Wegovy) review SR0841, clinician input ("any health care provider with experience managing obesity could prescribe semaglutide, noting this role should not be restricted to specialists alone"). canjhealthtechnol.ca
  3. Alberta College of Pharmacy. Additional prescribing authorization matters for safe pharmacy practice in Alberta (4,334 of 6,600+ clinical pharmacists hold APA as of 31 December 2025; prescribing "at initial access, for managing ongoing care, or to deprescribe"). 24 February 2026. abpharmacy.ca
  4. Canada's Drug Agency (CDA-AMC). Semaglutide (Wegovy) reimbursement recommendation SR0841, July 2025 ("Reimburse with conditions" only for adults with BMI 27 or more and established cardiovascular disease; price reduction of 67% required; $5,066 per patient per year). canjhealthtechnol.ca
  5. BC PharmaCare. Limited coverage drugs: semaglutide (Special Authority after inadequate control on metformin; up to 1 mg weekly), updated 21 April 2026. gov.bc.ca
  6. Ontario Ministry of Health. Ontario Drug Benefit Formulary search (Ozempic $227.94 per pen with ODB paying $78.141; generic semaglutide $78.141 per pen, interchangeable; Sevmia $325.048, off-formulary interchangeable; Rybelsus $7.5303 per tablet, Limited Use; tirzepatide not listed). Checked 12 October 2026. formulary.health.gov.on.ca
  7. Canada's Drug Agency (CDA-AMC). Semaglutide (Wegovy) SR0841, pharmacoeconomic review: FlexTouch "multiuse prefilled pens that contain 4 doses. The unit cost is $388.64 per pen (or $97.16 per dose)… the cost of pens is the same for all doses". canjhealthtechnol.ca
  8. Pedersen SD, Manjoo P, Dash S, Jain A, Pearce N, Poddar M. Canadian Adult Obesity Clinical Practice Guideline: Pharmacotherapy for Obesity Management in Adults, 2025 update. Obesity Canada, Version 3, 11 August 2025 (recommendations 1–13; contraindications; pregnancy, contraception and anesthesia notes; off-label prescribing). obesitycanada.ca (PDF)
  9. Alberta Blue Cross. Pharmacy Benefact 1330, July 2026 (generic semaglutide added to the Alberta Drug Benefit List from 1 July 2026, interchangeable with Ozempic; Dr. Reddy's shortage reported 10 July 2026). ab.bluecross.ca (PDF)
  10. Diabète Québec. Table of diabetes medications and their coverage (RAMQ exception drug criteria for Ozempic; Mounjaro private insurance only; NIHB Limited Use), March 2026. diabete.qc.ca (PDF)
  11. College of Physicians and Surgeons of Ontario. Virtual Care policy, updated June 2022 (same standard of care, including prescribing; consider whether a physical examination is required; comply with licensing requirements of the patient's jurisdiction). cpso.on.ca
  12. BC PharmaCare. Drug coverage decision: semaglutide (Wegovy), 18 December 2025 ("Non-benefit"; pCPA negotiations concluded without agreement on 1 December 2025; Novo Nordisk no longer seeking public coverage of Wegovy in Canada). gov.bc.ca (PDF)
  13. Government of Ontario. Get coverage for prescription drugs: Ontario Drug Benefit eligibility (OHIP+, 65 and older, long-term care, home care, Trillium Drug Program, Ontario Works, ODSP). Checked 12 October 2026. ontario.ca
  14. Gouvernement du Québec. Régime public d'assurance médicaments (who must join a private group plan and who is covered by the public plan). quebec.ca
  15. Global News. Novo Nordisk to cut Ozempic price as generics arrive ("only a small number of private insurers cover the use of the drugs for weight management"). 26 May 2026. globalnews.ca
  16. Benefits and Pensions Monitor. Can benefit plans stomach the $77 million weight-loss drug bill? (Telus Health data; plan controls such as prior authorization, BMI thresholds and step therapy). benefitsandpensionsmonitor.com
  17. Canada Revenue Agency. Details of medical expenses ("Prescription drugs and medications – that can lawfully be obtained for use by the person only if prescribed by a medical practitioner… recorded by a pharmacist"; "Needles and syringes – prescription needed"). Checked 12 October 2026. canada.ca
  18. Food and Drugs Act, R.S.C. 1985, c. F-27, section 3 and Schedule A.1 (no advertising to the general public as a treatment for listed conditions, including obesity and diabetes). Modified 28 September 2026. laws-lois.justice.gc.ca
  19. Food and Drug Regulations, C.R.C., c. 870, section C.01.044 (prescription-drug advertising to the public limited to brand name, proper name, common name, price and quantity). laws-lois.justice.gc.ca
  20. Health Canada. Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (advisory RA-81518: buy only from a licensed pharmacy; check the 8-digit DIN; misused logos and fake endorsements), updated 21 January 2026. recalls-rappels.canada.ca
  21. Health Canada. Unauthorized injectable peptide drugs seized and sold in Canada (41 peptides including tirzepatide and retatrutide; "illegal in Canada"), 1 August 2025. recalls-rappels.canada.ca
  22. Health Canada recalls: Semaglutide Injection (Dr. Reddy's) incorrect pen in package, 12 August 2026; Semaglutide Injection (Dr. Reddy's) out-of-specification impurity, 27 August 2026; Apo-Semaglutide incorrect dose display, 27 August 2026. impurity · pen · Apo
  23. Alberta College of Pharmacy. Unauthorized compounding of semaglutide-containing products is not permitted (Health Canada policy POL-0051). 10 June 2025. abpharmacy.ca
  24. Ontario College of Pharmacists. About Find a Pharmacy or Pharmacy Professional (every pharmacy operating in Ontario must be licensed by the College; public register). ocpinfo.com
  25. Provincial pharmacy regulators: Alberta College of Pharmacy (abpharmacy.ca) and Ordre des pharmaciens du Québec (opq.org). abpharmacy.ca · opq.org
  26. Novo Nordisk Canada. Wegovy (semaglutide injection) Product Monograph, revised 2 October 2026 (indications; single-use pen and FlexTouch storage: "Store below 30°C or in a refrigerator… for up to 8 weeks" after first use, single-use pen "below 30°C for a total of 28 days"; do not freeze; overdose: 1-844-POISON-X). Health Canada Drug Product Database · PDF
  27. Novo Nordisk Canada. Ozempic (semaglutide injection) Product Monograph, 13 July 2026 (indications; after first use 8 weeks below 30°C or refrigerated; never share a pen). PDF
  28. Novo Nordisk Canada. Rybelsus (semaglutide tablets) Product Monograph (empty stomach, no more than 120 mL of water, wait at least 30 minutes). PDF
  29. Health Canada. Drug Product Database and product monographs for generic semaglutide (Dr. Reddy's PM 00084444, authorized 28 April 2026, marketed 6 May 2026; Apotex PM 00084514, 1 May 2026, marketed 14 May 2026; Sevmia PM 00085157, 29 June 2026, "Approved"; Aspen PM 00085376 and 00085867; Sandoz PM 00086140, 16 September 2026) and Novo Nordisk's Plosbrio and Poviztra ("Approved"). Checked 12 October 2026. health-products.canada.ca
  30. Eli Lilly Canada. Zepbound (tirzepatide injection) Product Monograph, 11 June 2026 (indications; "The ZEPBOUND multi-dose KwikPen contains 4 doses"; dose steps; unrefrigerated below 30°C for up to 30 days; do not freeze). PDF
  31. Health Canada. Canada becomes the first G7 country to approve a generic version of semaglutide. News release, 28 April 2026. canada.ca
  32. Health Canada. Register of Innovative Drugs, 24 January 2025 edition (semaglutide data protection ends 4 January 2026); Benefits and Pensions Monitor on the lapsed patent. canada.ca (PDF) · benefitsandpensionsmonitor.com
  33. Global News / The Canadian Press. Generic semaglutide sales begin in Canada ("availability may vary across regions"). 20 May 2026. globalnews.ca
  34. Apotex. Press release on Sevmia approval ("a multi-use pre-filled pen delivering doses of 1 mg (4 mg per pen; 1.34 mg/mL)"), 30 June 2026. investors.apotex.com
  35. Health Canada. Canada launches new toll-free 1-844-POISON-X number for poison centres (Quebec: 1-800-463-5060). 20 March 2023. canada.ca
  36. Health Canada. Guidance on the importation of health products for personal use (GUI-0116), updated 13 July 2026 (drugs prescribed and filled in Canada; no more than a 90-day supply or a single course of treatment, whichever is less). canada.ca
  37. Benefits and Pensions Monitor (reporting The Globe and Mail). Eli Lilly cuts Canadian obesity drug prices (from 29 December 2025: $300 per 4-week supply for 2.5 and 5 mg; $420 for 7.5 and 10 mg). 19 December 2025. benefitsandpensionsmonitor.com
  38. Patented Medicine Prices Review Board (NPDUIS). Generic and biosimilar pricing policies (pCPA tiered framework: three or more generics, "25% … for oral solids; 35% for non-oral solids"). 15 January 2024. canada.ca

Last checked 12 Oct 2026 · Coverage, generics and prices re-checked monthly · Next full review due Jan 2027 · Report an error

How this guide was made. Written by the GLP Guidebook team from the sources above: Health Canada records, product monographs and advisories, provincial drug plans, Canada's Drug Agency, provincial regulators and named, dated news reports. It's general information, not medical advice. Talk to your family doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. In an emergency, call 911. For health advice that isn't an emergency, call 811 in most provinces and territories (Info-Santé 811 in Quebec). We don't sell, prescribe or recommend any brand, and we take no money from drug companies, pharmacies or clinics. How we write